High VLDL causes

Jump to: navigation, search

Very Low Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

High VLDL

Definition
Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Low VLDL

Definition
Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

High VLDL causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High VLDL causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High VLDL causes

CDC on High VLDL causes

High VLDL causes in the news

Blogs on High VLDL causes

Directions to Hospitals Treating Very low density lipoprotein

Risk calculators and risk factors for High VLDL causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Overview

High VLDL may be a consequence of inherited diseases that affect the lipid metabolism, or cab be due to secondary causes such as drugs and chronic liver disease.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning Diterpenoids
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect Azathioprine, bexarotene, calcineurin inhibitors, chlortalidone, corticosteroids, cyclosporine, desvenlafaxine, immunosuppressive agents, levonorgestrel, lopinavir, mycophenolate, nicotine, norgestrel, prednisone, progestin, protease inhibitors, rapamycin, rosiglitazone, sirolimus, thiazide, tocilizumab
Ear Nose Throat No underlying causes
Endocrine Acromegaly, Cushing's syndrome, dehydroepiandrosterone, diabetes mellitus type 2, hypercortisolism, hypothyroidism, polycystic ovarian syndrome, subclinical hypothyroidism
Environmental No underlying causes
Gastroenterologic Acute hepatitis, chronic liver disease, obstructive jaundice
Genetic Acid sphingomyelinase deficiency, apolipoprotein C-II deficiency, autosomal recessive hypercholesterolemia, familial combined hyperlipidemia, familial defective apolipoprotein B-100, familial hypercholesterolemia, familial hyperlipoproteinemia type 5, familial hypertriglyceridaemia, familial mixed hyperlipidaemia, IL 28B polymorphisms, lipoprotein lipase deficiency, Niemann-Pick disease, polygenic hypercholesterolemia
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease Gram negative sepsis, H. pylori infection, small bowel bacterial overgrowth syndrome
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic Chenodeoxycholic acid, high carbohydrate diet, high saturated fat diet, polygenic hypercholesterolemia, primary hyperlipoproteinemia, primary hypolipoproteinemia, selenium deficiency
Obstetric/Gynecologic Polycystic ovarian syndrome
Oncologic Lymphoma, multiple myeloma
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte Chronic kidney disease, nephrotic syndrome, uremia
Rheumatology/Immunology/Allergy Dysproteinemia, monoclonal gammopathy, multiple myeloma, paraproteinemia
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Alcoholism

Causes in Alphabetical Order

References

  1. 1.0 1.1 Durrington, P. (2003). "Dyslipidaemia.". Lancet. 362 (9385): 717–31. PMID 12957096. doi:10.1016/S0140-6736(03)14234-1.  Unknown parameter |month= ignored (help)
  2. 2.0 2.1 Covington, MB. (2004). "Omega-3 fatty acids.". Am Fam Physician. 70 (1): 133–40. PMID 15259529.  Unknown parameter |month= ignored (help)
  3. Kronenberg, F. (2005). "Dyslipidemia and nephrotic syndrome: recent advances.". J Ren Nutr. 15 (2): 195–203. PMID 15827892.  Unknown parameter |month= ignored (help)

Linked-in.jpg